Judgment of the Court (Fourth Chamber) of 21 March 2019.#Abraxis Bioscience LLC v Comptroller General of Patents.#Reference for a preliminary ruling — Medicinal product for human use — Supplementary protection certificate for medicinal products — Regulation (EC) No 469/2009 — Article 3(d) — Conditions for granting — Grant of first authorisation to place the product on the market as a medicinal product — Authorisation covering a product as a medicinal product constituting a new formulation of a known active ingredient.#Case C-443/17.